Microbial and Cytokine Signatures in Long COVID Patients

Part of paid clinical trials in Palo Alto, California.

Sponsor
Palo Alto Medical Foundation
Study ID
NCT07074158
Status
Enrolling By Invitation

Conditions

  • Post-Acute COVID-19 Syndrome

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

We aim at identifying potential biomarkers in plasma indicative of post-acute coronavirus SARS-CoV-2 Syndrome (Long COVID). Our case-control study will compare Long COVID patients to healthy patients from Sutter Health.

Key Dates

Start date
Jul 14, 2025
Status verified
Jul 2025
Primary completion
Jul 13, 2026
Completion
Oct 30, 2026

Study Design

Enrollment
150 participants (estimated)

Arms

  • Arm: Long COVID Subjects
    Long COVID patients with a duration of illness longer than 6 months or longer will be included in the study.
  • Arm: Healthy Controls
    Healthy controls, matched by age to a long COVID subject (+/-10 years and preferably by sex).

Primary Outcome Measure

Metagenomics [ Time Frame: Baseline ]

Locations (1)

FacilityCityStateZIPSite coordinators
Sutter Health Palo Alto CenterPalo AltoCalifornia94301-

Find similar trials in Palo Alto, CA

By research site
Sutter Health Palo Alto Center· Palo Alto, CA

Related Studies